New cancer drug begins human testing for Tough-to-Treat tumors
Disease control
Recruiting now
This is the first study in people testing a new drug called PHST001 for adults with advanced solid tumors that have returned or stopped responding to all available standard treatments. The main goals are to find a safe dose and see how the body handles the drug. Researchers will …
Phase: PHASE1 • Sponsor: Pheast Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC